VJHemOnc is committed to improving our service to you

EBMT 2020 | Efficacy of haploidentical SCT for R/R classical Hodgkin lymphoma

VJHemOnc is committed to improving our service to you

Ivan Moiseev

Ivan Moiseev, MD, PhD, First Saint Petersburg State Medical University, Saint Petersburg, Russia, discusses the efficacy of haploidentical stem cell transplantation (SCT) in patients with relapsed/refractory (R/R) classical Hodgkin lymphoma, in comparison to matched-related donors. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter